tirzepatide diverticulitis Is it safe to prescribe glucagon-like peptide‑1 (GLP‑1) receptor agonists for weight loss or glycemic control in a patient with diverticulosis? How Tirzepatide Support Medical Weight

Clinical Evidence: In a study involving healthy male subjects, GLP-1 administration resulted in increased renal sodium excretion (FeNa) from 1.6% (placebo) to 2.7% (GLP-1), indicating enhanced natriuresis

A new study published in JAMA Network Open has found that a significant number of adults prescribed GLP-1 receptor agonists (GLP-1 RAs) for weight loss stop taking them within the first year

Mid-morning snack (120 cal, 3g protein): One medium pear with ten walnut halves

An implant which releases diabetes medication when it senses caffeine in the blood is being investigated as a future treatment

Are you struggling with thinning hair, weak follicles, or slow hair growth that leaves you feeling self-conscious